Langlai Technology
About:
Langlai Technology is a clinical-stage innovative drug research and development company.
Website: https://www.createrna.com
Top Investors: Lilly Asia Ventures, Vinno Capital
Description:
Langlai Technology is a clinical-stage innovative drug research and development company. Adhering to the dual-drive strategy of synchronously improving the R&D pipeline and platform construction, it has built a full-process new drug R&D process from concept verification, candidate compound screening, preclinical druggability development to clinical research. system.
Total Funding Amount:
500M CNY
Headquarters Location:
Wuhan, Hubei, China
Founded Date:
2013-01-01
Contact Email:
BD(AT)createrna.com
Founders:
Number of Employees:
101-250
Last Funding Date:
2023-06-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai